LS Investment Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-669
| Closed | -$171K | – | 863 |
|
|
2020
Q4 | $171K | Hold |
669
| – | – | 0.01% | 841 |
|
|
2020
Q3 | $166K | Hold |
669
| – | – | 0.01% | 731 |
|
|
2020
Q2 | $232K | Buy |
669
+27
| +4% | +$9.36K | 0.01% | 663 |
|
|
2020
Q1 | $172K | Hold |
642
| – | – | 0.01% | 686 |
|
|
2019
Q4 | $208K | Sell |
642
-172
| -21% | -$55.7K | 0.01% | 789 |
|
|
2019
Q3 | $223K | Buy |
814
+261
| +47% | +$71.5K | 0.01% | 735 |
|
|
2019
Q2 | $295K | Hold |
553
| – | – | 0.02% | 630 |
|
|
2019
Q1 | $279K | Buy |
553
+15
| +3% | +$7.57K | 0.02% | 655 |
|
|
2018
Q4 | $265K | Buy |
538
+13
| +2% | +$6.4K | 0.02% | 645 |
|
|
2018
Q3 | $480K | Sell |
525
-13
| -2% | -$11.9K | 0.03% | 514 |
|
|
2018
Q2 | $394K | Buy |
538
+175
| +48% | +$128K | 0.02% | 598 |
|
|
2018
Q1 | $578K | Sell |
363
-47
| -11% | -$74.8K | 0.03% | 445 |
|
|
2017
Q4 | $367K | Buy |
410
+29
| +8% | +$26K | 0.02% | 633 |
|
|
2017
Q3 | $137K | Sell |
381
-59
| -13% | -$21.2K | 0.01% | 1065 |
|
|
2017
Q2 | $129K | Buy |
440
+36
| +9% | +$10.6K | 0.01% | 1056 |
|
|
2017
Q1 | $142K | Sell |
404
-21
| -5% | -$7.38K | 0.01% | 993 |
|
|
2016
Q4 | $78K | Buy |
425
+41
| +11% | +$7.53K | 0.01% | 1120 |
|
|
2016
Q3 | $99K | Buy |
384
+7
| +2% | +$1.81K | 0.01% | 1009 |
|
|
2016
Q2 | $81K | Buy |
377
+16
| +4% | +$3.44K | 0.01% | 1051 |
|
|
2016
Q1 | $74K | Buy |
361
+33
| +10% | +$6.77K | 0.01% | 995 |
|
|
2015
Q4 | $83K | Sell |
328
-8
| -2% | -$2.02K | 0.01% | 935 |
|
|
2015
Q3 | $55K | Hold |
336
| – | – | ﹤0.01% | 1097 |
|
|
2015
Q2 | $63K | Buy |
+336
| New | +$63K | ﹤0.01% | 1076 |
|